- Home
- MNPR vs KIDS Comparison
MNPR vs KIDS Comparison
Compare MNPR & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNPR | KIDS |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 531.6M | 524.3M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MNPR | KIDS |
|---|---|---|
| Price | $70.61 | $17.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $97.83 | $24.75 |
| AVG Volume (30 Days) | ★ 191.8K | 176.7K |
| Earning Date | 11-13-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $227,410,000.00 |
| Revenue This Year | N/A | $16.58 |
| Revenue Next Year | N/A | $12.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.90 |
| 52 Week Low | $21.00 | $15.28 |
| 52 Week High | $105.00 | $27.60 |
Technical Indicators
Market Signals| Indicator | MNPR | KIDS |
|---|---|---|
| Relative Strength Index (RSI) | 41.11 | 46.86 |
| Support Level | $64.25 | $16.88 |
| Resistance Level | $74.34 | $18.36 |
| Average True Range (ATR) | 4.79 | 0.72 |
| MACD | -0.53 | -0.12 |
| Stochastic Oscillator | 31.45 | 20.00 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.